Cresco Labs Inc
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes… Read more
Market Cap & Net Worth: Cresco Labs Inc (CRLBF)
Cresco Labs Inc (OTCQX:CRLBF) has a market capitalization of $201.74 Million ($201.74 Million) as of March 19, 2026. Listed on the OTCQX stock exchange, this USA-based company holds position #15110 globally and #5989 in its home market, demonstrating a -21.63% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Cresco Labs Inc's stock price $0.59 by its total outstanding shares 340486810 (340.49 Million).
Cresco Labs Inc Market Cap History: 2018 to 2025
Cresco Labs Inc's market capitalization history from 2018 to 2025. Data shows change from $2.30 Billion to $201.74 Million (-28.48% CAGR).
Cresco Labs Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Cresco Labs Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.55x
Cresco Labs Inc's market cap is 0.55 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $2.30 Billion | $43.25 Million | -$1.92 Million | 53.10x | N/A |
| 2019 | $2.34 Billion | $128.53 Million | -$43.20 Million | 18.17x | N/A |
| 2020 | $3.36 Billion | $476.25 Million | -$81.92 Million | 7.05x | N/A |
| 2021 | $2.27 Billion | $821.68 Million | -$319.60 Million | 2.76x | N/A |
| 2022 | $612.88 Million | $842.68 Million | -$212.05 Million | 0.73x | N/A |
| 2023 | $461.70 Million | $770.88 Million | -$175.52 Million | 0.60x | N/A |
| 2024 | $401.77 Million | $724.34 Million | -$74.44 Million | 0.55x | N/A |
Competitor Companies of CRLBF by Market Capitalization
Companies near Cresco Labs Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Cresco Labs Inc by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Cresco Labs Inc Historical Marketcap From 2018 to 2025
Between 2018 and today, Cresco Labs Inc's market cap moved from $2.30 Billion to $ 201.74 Million, with a yearly change of -28.48%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $201.74 Million | -49.79% |
| 2024 | $401.77 Million | -12.98% |
| 2023 | $461.70 Million | -24.67% |
| 2022 | $612.88 Million | -73.01% |
| 2021 | $2.27 Billion | -32.39% |
| 2020 | $3.36 Billion | +43.85% |
| 2019 | $2.34 Billion | +1.66% |
| 2018 | $2.30 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Cresco Labs Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $201.74 Million USD |
| MoneyControl | $201.74 Million USD |
| MarketWatch | $201.74 Million USD |
| marketcap.company | $201.74 Million USD |
| Reuters | $201.74 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.